EasyJet shares: What I’d do given the rally

With the vaccine candidate data and the company’s financial position, Jay Yao writes what he’d do given the recent rally.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

EasyJet (LSE:EZJ) is one of the leading low cost airlines in Europe. In 2020, shares have fallen on tough times due to the pandemic. Year-to-date, easyJet shares have declined over 40% and the company has had to raise money from shareholders. 

With the recent positive vaccine candidate news, however, easyJet shares have rallied in the past month. Given the better than expected potential efficacy of Pfizer‘s and Moderna’s vaccine candidates, there is more hope that things will return to normal faster. 

In view of the rally, here’s what I’d do with easyJet shares.

EasyJet shares: The company has many attractive qualities

To me, EasyJet has many attractive qualities. First, the airline is well positioned in key markets in Europe with large populations and substantial GDP. The company also has a strong brand where many customers use the airline more than once. 

With its proximity to many potential travellers and repeat customers, the airline can spend less on marketing to get business. To me, the marketing advantage makes easyJet’s already low cost base even more of a competitive advantage. 

Second, the airline is attractive to me because its business focuses on the short haul/leisure markets. With the data so far, many analysts expect the short haul market to rebound faster than the long haul market. 

A faster demand rebound could mean a faster earnings rebound. 

When will air travel recover?

In terms of when air travel will recover, expectations were pretty gloomy but have recently brightened. While easyJet hasn’t given guidance past the first quarter of next financial year, some other airlines have given their outlooks. 

According to the management of fellow low-cost airline Ryanair, the easyJet competitor expects a pretty decent recovery with passenger volumes reaching 75%–80% of their pre-pandemic levels by next summer, assuming vaccines are developed by spring. 

Ryanair CEO Michael O’Leary said, “I’ve heard a lot of rubbish coming from legacy airlines that it’ll be 2035 till the volumes come back. Rubbish. Volumes will go back in 2021 or 2022 pretty quickly – they will go back because Ryanair will discount prices, hotels will discount.”

Near-term challenges

Although next summer could bring good news, the near term could be challenging. EasyJet burned £651m for the quarter ended 30 September. It could be a tough quarter ending on the last day of December too, which is the company’s first quarter of fiscal year 2021. EasyJet said, ‘based on current travel restrictions in the markets in which we operate, easyJet expects to fly no more than c.20% of planned capacity for Q1 2021’. 

Given the current enterprise value and the potential cash burn until summer, I’d follow easyJet shares but I’d wait until there is more data and guidance before making any decision. 

There is currently still a lot of uncertainty given future demand, the vaccine approval timeline, and the distribution of vaccines. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jay Yao has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »